Urica Therapeutics
About:
Urica Therapeutics is a clinical-stage biopharmaceutical company developing pharmaceutical products to treat gout and kidney diseases.
Website: https://uricatherapeutics.com/
Description:
Urica Therapeutics is a clinical-stage biopharmaceutical company focusing on the development and commercialization of pharmaceutical products to treat gout and chronic kidney diseases. Urica is a subsidiary company of Fortress Biotech.
Total Funding Amount:
$2.53M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Miami, Florida, United States
Founded Date:
2021-01-01
Founders:
Number of Employees:
1-10
Last Funding Date:
2023-01-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai